(FDUS) Fidus Investment - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US3165001070
Stock:
Total Rating 18
Risk 61
Buy Signal -0.59
| Risk 5d forecast | |
|---|---|
| Volatility | 27.3% |
| Relative Tail Risk | -1.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.73 |
| Alpha | -24.61 |
| Character TTM | |
|---|---|
| Beta | 0.508 |
| Beta Downside | 0.955 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.94% |
| CAGR/Max DD | 0.35 |
EPS (Earnings per Share)
Revenue
Description: FDUS Fidus Investment
Fidus Investment Corporation is a business development company. It specializing in leveraged buyouts, refinancings, change of ownership transactions, recapitalizations, strategic acquisitions, mezzanine, growth capital, business expansion, lower middle market investments, debt investments, subordinated and second lien loans, senior secured and unitranche debt, preferred equity, warrants, subordinated debt, senior subordinated notes, junior secured loans, and unitranche loans. It does not invest in turnarounds or distressed situations. The fund prefers to invest in aerospace and defense, business services, consumer products and services including retail, food, and beverage, healthcare products and services, industrial products and services, information technology services, niche manufacturing, transportation and logistics, and value-added distribution sectors. It seeks to invest in companies based in United States. The fund typically invests between $5 million and $30 million per transaction in companies with annual revenues between $10 million and $150 million and an annual EBITDA between $5 million and $30 million, but it can occasionally invest in larger or smaller companies. The fund typically invests between $5 million and $15 million in debt investment. It seeks to acquire minority equity stakes and board observation rights in conjunction with its investments.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 73.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.10 > 0.02 and ΔFCF/TA -15.87 > 1.0 |
| NWC/Revenue: 68.35% < 20% (prev 34.06%; Δ 34.29% < -1%) |
| CFO/TA -0.10 > 3% & CFO -147.0m > Net Income 73.8m |
| Net Debt (160.6m) to EBITDA (66.9m): 2.40 < 3 |
| Current Ratio: 25.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (37.0m) vs 12m ago 9.00% < -2% |
| Gross Margin: 84.31% > 18% (prev 0.80%; Δ 8350 % > 0.5%) |
| Asset Turnover: 9.92% > 50% (prev 9.77%; Δ 0.16% > 0%) |
| Interest Coverage Ratio: 1.70 > 6 (EBITDA TTM 66.9m / Interest Expense TTM 29.6m) |
Altman Z'' 2.02
| A: 0.06 (Total Current Assets 91.4m - Total Current Liabilities 3.57m) / Total Assets 1.43b |
| B: 0.07 (Retained Earnings 94.0m / Total Assets 1.43b) |
| C: 0.04 (EBIT TTM 50.4m / Avg Total Assets 1.30b) |
| D: 1.08 (Book Value of Equity 741.9m / Total Liabilities 684.6m) |
| Altman-Z'' Score: 2.02 = BBB |
Beneish M
| DSRI: 1.25 (Receivables 21.4m/15.1m, Revenue 128.5m/113.7m) |
| GMI: 0.95 (GM 84.31% / 80.39%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.13 (Revenue 128.5m / 113.7m) |
| TATA: 0.15 (NI 73.8m - CFO -147.0m) / TA 1.43b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of FDUS shares?
As of March 04, 2026, the stock is trading at USD 18.09 with a total of 240,627 shares traded.
Over the past week, the price has changed by -1.15%, over one month by -5.09%, over three months by -6.35% and over the past year by -13.58%.
Over the past week, the price has changed by -1.15%, over one month by -5.09%, over three months by -6.35% and over the past year by -13.58%.
Is FDUS a buy, sell or hold?
Fidus Investment has received a consensus analysts rating of 4.25.
Therefore, it is recommended to buy FDUS.
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FDUS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 22 | 21.6% |
| Analysts Target Price | 22 | 21.6% |
FDUS Fundamental Data Overview March 02, 2026
P/E Trailing = 7.5684
P/E Forward = 9.3197
P/S = 4.2674
P/B = 0.9073
P/EG = 3.59
Revenue TTM = 128.5m USD
EBIT TTM = 50.4m USD
EBITDA TTM = 66.9m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 230.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 160.6m USD (from netDebt column, last quarter)
Enterprise Value = 805.7m USD (645.1m + Debt 230.6m - CCE 70.0m)
Interest Coverage Ratio = 1.70 (Ebit TTM 50.4m / Interest Expense TTM 29.6m)
EV/FCF = -5.48x (Enterprise Value 805.7m / FCF TTM -147.0m)
FCF Yield = -18.25% (FCF TTM -147.0m / Enterprise Value 805.7m)
FCF Margin = -114.4% (FCF TTM -147.0m / Revenue TTM 128.5m)
Net Margin = 57.46% (Net Income TTM 73.8m / Revenue TTM 128.5m)
Gross Margin = 84.31% ((Revenue TTM 128.5m - Cost of Revenue TTM 20.2m) / Revenue TTM)
Gross Margin QoQ = none% (prev 76.69%)
Tobins Q-Ratio = 0.56 (Enterprise Value 805.7m / Total Assets 1.43b)
Interest Expense / Debt = 4.09% (Interest Expense 9.42m / Debt 230.6m)
Taxrate = 2.95% (2.25m / 76.1m)
NOPAT = 48.9m (EBIT 50.4m * (1 - 2.95%))
Current Ratio = 25.62 (Total Current Assets 91.4m / Total Current Liabilities 3.57m)
Debt / Equity = 0.31 (Debt 230.6m / totalStockholderEquity, last quarter 741.9m)
Debt / EBITDA = 2.40 (Net Debt 160.6m / EBITDA 66.9m)
Debt / FCF = -1.09 (negative FCF - burning cash) (Net Debt 160.6m / FCF TTM -147.0m)
Total Stockholder Equity = 705.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.70% (Net Income 73.8m / Total Assets 1.43b)
RoE = 10.46% (Net Income TTM 73.8m / Total Stockholder Equity 705.8m)
RoCE = 3.54% (EBIT 50.4m / Capital Employed (Total Assets 1.43b - Current Liab 3.57m))
RoIC = 3.99% (NOPAT 48.9m / Invested Capital 1.23b)
WACC = 6.78% (E(645.1m)/V(875.7m) * Re(7.79%) + D(230.6m)/V(875.7m) * Rd(4.09%) * (1-Tc(0.03)))
Discount Rate = 7.79% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 18.41%
[DCF] Fair Price = unknown (Cash Flow -147.0m)
EPS Correlation: 27.22 | EPS CAGR: 5.20% | SUE: 0.86 | # QB: 1
Revenue Correlation: 79.10 | Revenue CAGR: 18.63% | SUE: -2.66 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.50 | Chg7d=+0.014 | Chg30d=+0.014 | Revisions Net=-2 | Analysts=2
EPS current Year (2026-12-31): EPS=1.98 | Chg7d=+0.056 | Chg30d=+0.056 | Revisions Net=-1 | Growth EPS=-7.0% | Growth Revenue=+8.6%
EPS next Year (2027-12-31): EPS=1.93 | Chg7d=-0.022 | Chg30d=-0.022 | Revisions Net=-1 | Growth EPS=-2.4% | Growth Revenue=-0.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -5.3% (Discount Rate 7.9% - Earnings Yield 13.2%)
[Growth] Growth Spread = +8.4% (Analyst 3.2% - Implied -5.3%)
P/E Forward = 9.3197
P/S = 4.2674
P/B = 0.9073
P/EG = 3.59
Revenue TTM = 128.5m USD
EBIT TTM = 50.4m USD
EBITDA TTM = 66.9m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 230.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 160.6m USD (from netDebt column, last quarter)
Enterprise Value = 805.7m USD (645.1m + Debt 230.6m - CCE 70.0m)
Interest Coverage Ratio = 1.70 (Ebit TTM 50.4m / Interest Expense TTM 29.6m)
EV/FCF = -5.48x (Enterprise Value 805.7m / FCF TTM -147.0m)
FCF Yield = -18.25% (FCF TTM -147.0m / Enterprise Value 805.7m)
FCF Margin = -114.4% (FCF TTM -147.0m / Revenue TTM 128.5m)
Net Margin = 57.46% (Net Income TTM 73.8m / Revenue TTM 128.5m)
Gross Margin = 84.31% ((Revenue TTM 128.5m - Cost of Revenue TTM 20.2m) / Revenue TTM)
Gross Margin QoQ = none% (prev 76.69%)
Tobins Q-Ratio = 0.56 (Enterprise Value 805.7m / Total Assets 1.43b)
Interest Expense / Debt = 4.09% (Interest Expense 9.42m / Debt 230.6m)
Taxrate = 2.95% (2.25m / 76.1m)
NOPAT = 48.9m (EBIT 50.4m * (1 - 2.95%))
Current Ratio = 25.62 (Total Current Assets 91.4m / Total Current Liabilities 3.57m)
Debt / Equity = 0.31 (Debt 230.6m / totalStockholderEquity, last quarter 741.9m)
Debt / EBITDA = 2.40 (Net Debt 160.6m / EBITDA 66.9m)
Debt / FCF = -1.09 (negative FCF - burning cash) (Net Debt 160.6m / FCF TTM -147.0m)
Total Stockholder Equity = 705.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.70% (Net Income 73.8m / Total Assets 1.43b)
RoE = 10.46% (Net Income TTM 73.8m / Total Stockholder Equity 705.8m)
RoCE = 3.54% (EBIT 50.4m / Capital Employed (Total Assets 1.43b - Current Liab 3.57m))
RoIC = 3.99% (NOPAT 48.9m / Invested Capital 1.23b)
WACC = 6.78% (E(645.1m)/V(875.7m) * Re(7.79%) + D(230.6m)/V(875.7m) * Rd(4.09%) * (1-Tc(0.03)))
Discount Rate = 7.79% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 18.41%
[DCF] Fair Price = unknown (Cash Flow -147.0m)
EPS Correlation: 27.22 | EPS CAGR: 5.20% | SUE: 0.86 | # QB: 1
Revenue Correlation: 79.10 | Revenue CAGR: 18.63% | SUE: -2.66 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.50 | Chg7d=+0.014 | Chg30d=+0.014 | Revisions Net=-2 | Analysts=2
EPS current Year (2026-12-31): EPS=1.98 | Chg7d=+0.056 | Chg30d=+0.056 | Revisions Net=-1 | Growth EPS=-7.0% | Growth Revenue=+8.6%
EPS next Year (2027-12-31): EPS=1.93 | Chg7d=-0.022 | Chg30d=-0.022 | Revisions Net=-1 | Growth EPS=-2.4% | Growth Revenue=-0.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -5.3% (Discount Rate 7.9% - Earnings Yield 13.2%)
[Growth] Growth Spread = +8.4% (Analyst 3.2% - Implied -5.3%)